Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safflower Xiaoyao Tablets vs Xiaoyao Pill for Premenstrual Syndrome (liver depression and qi stagnation)
ChiCTR2200057224Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of safflower xiaoyao tablets in premenstrual syndrome (PMS) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Daily Record of Severity of Problems (DRSP) score. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
safflower xiaoyao tablets
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on ChiCTR2200057224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057224.